# CAR-37 T Cells in Hematologic Malignancies

> **NCT04136275** · PHASE1 · COMPLETED · sponsor: **Marcela V. Maus, M.D.,Ph.D.** · enrollment: 6 (actual)

## Conditions studied

- Hematologic Malignancy
- Leukemia
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, T-Cell
- Lymphoma, Non-Hodgkin

## Interventions

- **BIOLOGICAL:** CAR-37 T cells

## Key facts

- **NCT ID:** NCT04136275
- **Lead sponsor:** Marcela V. Maus, M.D.,Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-19
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-03-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04136275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04136275, "CAR-37 T Cells in Hematologic Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04136275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*